These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 15675131)

  • 41. Ghrelin and adipokines as circulating markers of disease activity in patients with Takayasu arteritis.
    Yilmaz H; Gerdan V; Kozaci D; Solmaz D; Akar S; Can G; Gulcu A; Goktay Y; Sari I; Birlik M; Akkoc N; Onen F
    Arthritis Res Ther; 2012 Dec; 14(6):R272. PubMed ID: 23259466
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Takayasu's arteritis: underestimated cause of hypertension].
    Cybulska I; Makowiecka-Cieśla M; Florczak E
    Przegl Lek; 2001; 58(6):490-4. PubMed ID: 11816738
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Endothelial progenitor cells and vascular endothelial growth factor in patients with Takayasu's arteritis.
    Machado LSG; Oliveira ACD; Semedo-Kuriki P; de Souza AWS; Sato EI
    Adv Rheumatol; 2018 Aug; 58(1):24. PubMed ID: 30657078
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Beneficial effects of leflunomide in glucocorticoid- and methotrexate-resistant Takayasu's arteritis.
    Haberhauer G; Kittl EM; Dunky A; Feyertag J; Bauer K
    Clin Exp Rheumatol; 2001; 19(4):477-8. PubMed ID: 11491512
    [No Abstract]   [Full Text] [Related]  

  • 45. Anti-annexin V antibodies in Takayasu's arteritis: prevalence and relationship with disease activity.
    Tripathy NK; Sinha N; Nityanand S
    Clin Exp Immunol; 2003 Nov; 134(2):360-4. PubMed ID: 14616799
    [TBL] [Abstract][Full Text] [Related]  

  • 46. NMR-Based Serum Metabolomics of Patients with Takayasu Arteritis: Relationship with Disease Activity.
    Jain A; Kumar D; Guleria A; Misra DP; Zanwar A; Chaurasia S; Kumar S; Kumar U; Mishra SK; Goel R; Danda D; Misra R
    J Proteome Res; 2018 Sep; 17(9):3317-3324. PubMed ID: 30095916
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Enzyme-linked immunosorbent assay and immunoblot study in Takayasu's arteritis patients.
    Dhingra R; Chopra P; Talwar KK; Kumar R
    Indian Heart J; 1998; 50(4):428-32. PubMed ID: 9835204
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Treatment of Takayasu arteritis with the IL-6R antibody tocilizumab vs. cyclophosphamide.
    Kong X; Zhang X; Lv P; Cui X; Ma L; Chen H; Liu H; Lin J; Jiang L
    Int J Cardiol; 2018 Sep; 266():222-228. PubMed ID: 29729868
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Antigenic targets and pathogenicity of anti-aortic endothelial cell antibodies in Takayasu arteritis.
    Chauhan SK; Tripathy NK; Nityanand S
    Arthritis Rheum; 2006 Jul; 54(7):2326-33. PubMed ID: 16802373
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Circulating B lymphocytes producing autoantibodies to endothelial cells play a role in the pathogenesis of Takayasu arteritis.
    Wang H; Ma J; Wu Q; Luo X; Chen Z; Kou L
    J Vasc Surg; 2011 Jan; 53(1):174-80. PubMed ID: 20832232
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pyoderma gangrenosum associated with Takayasu's arteritis.
    Ujiie H; Sawamura D; Yokota K; Nishie W; Shichinohe R; Shimizu H
    Clin Exp Dermatol; 2004 Jul; 29(4):357-9. PubMed ID: 15245528
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Takayasu's arteritis: a cause of prolonged arterial stiffness.
    Ng WF; Fantin F; Ng C; Dockery F; Schiff R; Davies KA; Rajkumar C; Mason JC
    Rheumatology (Oxford); 2006 Jun; 45(6):741-5. PubMed ID: 16403827
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Analysis of the clinical profile, autoimmune phenomena and T cell subsets (CD4 and CD8) in Takayasu's arteritis: a hospital-based study.
    Uppal SS; Verma S
    Clin Exp Rheumatol; 2003; 21(6 Suppl 32):S112-6. PubMed ID: 14740436
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Interleukin (IL)-12, IL-2, and IL-6 gene polymorphisms in Takayasu's arteritis from Turkey.
    Saruhan-Direskeneli G; Biçakçigil M; Yilmaz V; Kamali S; Aksu K; Fresko I; Akkoç N; Kiraz S; Ozer HT; Tunç E; Yücel E; Karaarslan Y; Uyar FA; Doganavşargil E; Inanc M; Direskeneli H;
    Hum Immunol; 2006 Sep; 67(9):735-40. PubMed ID: 17002904
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Long-term efficacy and improvement of health-related quality of life in patients with Takayasu's arteritis treated with infliximab.
    Quartuccio L; Schiavon F; Zuliani F; Carraro V; Catarsi E; Tavoni AG; Bombardieri S; Punzi L; De Vita S
    Clin Exp Rheumatol; 2012; 30(6):922-8. PubMed ID: 23044074
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Implication of oxidative stress and its correlation with activity of matrix metalloproteinases in patients with Takayasu's arteritis disease.
    Mahajan N; Dhawan V; Malik S; Jain S
    Int J Cardiol; 2010 Nov; 145(2):286-288. PubMed ID: 19913312
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Glucocorticoid resistance in a girl with Takayasu's arteritis.
    Drigo I; Saccari A; Bacchin C; Barbi E; Bartoli F; Decorti G; Ventura A
    Ann Rheum Dis; 2006 May; 65(5):689-91. PubMed ID: 16611870
    [No Abstract]   [Full Text] [Related]  

  • 58. Takayasu's arteritis in Mexico: a clinical review of 44 consecutive cases.
    Robles M; Reyes PA
    Clin Exp Rheumatol; 1994; 12(4):381-8. PubMed ID: 7955601
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Serum leptin, a potential predictor of long-term angiographic progression in Takayasu's arteritis.
    Ma L; Yu W; Dai X; Yin M; Wang Y; Sun Y; Kong X; Cui X; Wu S; Ji Z; Ma L; Chen H; Lin J; Jiang L
    Int J Rheum Dis; 2019 Dec; 22(12):2134-2142. PubMed ID: 31595672
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Association of interleukin-6 and interleukin-10 expression, gene polymorphisms, and Takayasu arteritis in a Chinese Han population.
    Gao Q; Lv N; Dang A; Li Z; Ye J; Zheng D
    Clin Rheumatol; 2019 Jan; 38(1):143-148. PubMed ID: 30171380
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.